Mostafa Yakoot

548 total citations
32 papers, 420 citations indexed

About

Mostafa Yakoot is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mostafa Yakoot has authored 32 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 9 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Mostafa Yakoot's work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). Mostafa Yakoot is often cited by papers focused on Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (6 papers). Mostafa Yakoot collaborates with scholars based in Egypt, Poland and United Kingdom. Mostafa Yakoot's co-authors include Sherine Helmy, Mortada El‐Shabrawi, Hisham R El‐Khayat, Ahmed M. Salem, Ahmed Hamed Salem, Enas Kamal, Naglaa M. Kamal, Dina Attia, Yasser Fouad and Rehab F. Abdel‐Rahman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Alimentary Pharmacology & Therapeutics and Acta Paediatrica.

In The Last Decade

Mostafa Yakoot

32 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mostafa Yakoot Egypt 13 155 143 61 49 45 32 420
Qingqing Liu China 10 42 0.3× 94 0.7× 27 0.4× 44 0.9× 17 0.4× 38 498
Martina Taddia Italy 4 143 0.9× 213 1.5× 24 0.4× 44 0.9× 2 0.0× 5 628
Muharrem Bayrak Türkiye 10 102 0.7× 132 0.9× 20 0.3× 10 0.2× 7 0.2× 24 278
Anna Salas Spain 13 127 0.8× 136 1.0× 5 0.1× 73 1.5× 3 0.1× 26 382
Mahsa Jalili Iran 10 15 0.1× 58 0.4× 10 0.2× 18 0.4× 9 0.2× 38 324
Milenko Bevanda Bosnia and Herzegovina 11 16 0.1× 41 0.3× 15 0.2× 17 0.3× 34 0.8× 28 294
Mehdi Pasalar Iran 13 10 0.1× 34 0.2× 183 3.0× 16 0.3× 8 0.2× 74 517
Fatemeh Heydarpour Iran 12 8 0.1× 57 0.4× 32 0.5× 11 0.2× 11 0.2× 47 394
Susan Kaufman Canada 9 25 0.2× 44 0.3× 7 0.1× 11 0.2× 33 0.7× 14 359
Hiroshi Matsufuji Japan 13 20 0.1× 21 0.1× 9 0.1× 5 0.1× 39 0.9× 48 510

Countries citing papers authored by Mostafa Yakoot

Since Specialization
Citations

This map shows the geographic impact of Mostafa Yakoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa Yakoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa Yakoot more than expected).

Fields of papers citing papers by Mostafa Yakoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa Yakoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa Yakoot. The network helps show where Mostafa Yakoot may publish in the future.

Co-authorship network of co-authors of Mostafa Yakoot

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa Yakoot. A scholar is included among the top collaborators of Mostafa Yakoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa Yakoot. Mostafa Yakoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakoot, Mostafa, et al.. (2020). Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study. SSRN Electronic Journal. 2 indexed citations
2.
Yakoot, Mostafa, et al.. (2019). <p>Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1659–1665. 7 indexed citations
3.
El‐Shabrawi, Mortada, Laila M. Sherief, Mostafa Yakoot, et al.. (2019). Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy. World Journal of Clinical Cases. 7(16). 2247–2255. 12 indexed citations
4.
Yakoot, Mostafa, et al.. (2018). Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection. Journal of Pediatric Gastroenterology and Nutrition. 67(1). 86–89. 32 indexed citations
5.
6.
Yakoot, Mostafa, et al.. (2016). Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy. Drug Design Development and Therapy. Volume 10. 2659–2667. 10 indexed citations
7.
8.
9.
Yakoot, Mostafa, Nemat Yassin, Siham M. El‐Shenawy, et al.. (2015). Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of&nbsp;osteoarthritis. Drug Design Development and Therapy. 9. 1491–1491. 16 indexed citations
10.
Yakoot, Mostafa, et al.. (2014). Clinical efficacy of Spasmofen&reg; suppository in the emergency treatment of renal colic: a randomized, double-blind, double-dummy comparative trial. Drug Design Development and Therapy. 8. 405–405. 8 indexed citations
11.
Yakoot, Mostafa. (2013). Bridging the gap between alternative medicine and evidence-based medicine. Journal of Pharmacology and Pharmacotherapeutics. 4(2). 83–85. 6 indexed citations
12.
Yakoot, Mostafa, et al.. (2013). Effect of Memo&reg;, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment. Clinical Interventions in Aging. 8. 975–975. 31 indexed citations
13.
Yakoot, Mostafa. (2012). Vitamin E and Omega-3: What to believe: Observational studies or randomized controlled trials?. SHILAP Revista de lepidopterología. 13(2). 66–66. 2 indexed citations
14.
Yakoot, Mostafa, et al.. (2012). Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial. BMC Gastroenterology. 12(1). 32–32. 44 indexed citations
15.
Yakoot, Mostafa. (2012). Phenylpropanolamine and the hemorrhagic stroke: A new search for the culprit. Journal of Pharmacology and Pharmacotherapeutics. 3(1). 4–6. 4 indexed citations
16.
Yakoot, Mostafa. (2011). Eosinophilic Digestive Disease (EDD) and Allergic Bronchial Asthma; Two Diseases or Expression of One Disease in Two Systems?. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 37(1). 18–18. 7 indexed citations
17.
Yakoot, Mostafa & Ahmed Hamed Salem. (2011). Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold. International Journal of General Medicine. 4. 45–45. 19 indexed citations
18.
Yakoot, Mostafa, et al.. (2011). Effectiveness of a Herbal Formula in Women with Menopausal Syndrome. PubMed. 18(5). 264–268. 15 indexed citations
19.
Yakoot, Mostafa, et al.. (2011). Pilot study of the efficacy and safety of lettuce seed oil in patients with sleep disorders. International Journal of General Medicine. 4. 451–451. 36 indexed citations
20.
Yakoot, Mostafa. (2010). A short review of the anthelmintic role of mirazid. Arquivos de Gastroenterologia. 47(4). 393–394. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingqing Liu Breakdown of academic impact, for papers by Martina Taddia Breakdown of academic impact, for papers by Muharrem Bayrak Breakdown of academic impact, for papers by Anna Salas Breakdown of academic impact, for papers by Mahsa Jalili Breakdown of academic impact, for papers by Milenko Bevanda Breakdown of academic impact, for papers by Mehdi Pasalar Breakdown of academic impact, for papers by Fatemeh Heydarpour Breakdown of academic impact, for papers by Susan Kaufman Breakdown of academic impact, for papers by Hiroshi Matsufuji
Rankless by CCL
2026